Imperial College London


Faculty of MedicineDepartment of Medicine

Professor of Infectious Diseases



+44 (0)20 7594 3903g.cooke




Infectious Diseases SectionWinston Churchill WingSt Mary's Campus





Graham Cooke is NIHR Professor of Infectious Diseases based within the Division of Infectious Diseases at the Wright-Fleming Institute. He trained in Oxford, London and South Africa. Prior to joining Imperial he was based at the Africa Health Research Institute in KwaZulu-Natal.

His current work is focussed on precision medicine for management of infectious diseases and access to medicines, particularly for HIV/viral hepatitis, tuberculosis and bacterial sepsis. He co-chairs the WHO Essential Medicines List and chairs the WHO EML antibiotics working group. 


Funding: NIHR, Wellcome Trust, MRC, Médecins sans Frontières, BRC Imperial College


Follow on twitter: @grahamscooke

Selected Publications

Journal Articles

Cooke GS, Andrieux-Meyer I, Applegate TL, et al., 2019, Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission, The Lancet Gastroenterology and Hepatology, Vol:4, ISSN:2468-1253, Pages:135-184

Heffernan A, Cooke GS, Nayagam S, et al., 2019, Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model., Lancet

Ansari MA, Pedergnana V, Ip CLC, et al., 2017, Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus, Nature Genetics, Vol:49, ISSN:1061-4036, Pages:666-+

Gurrala R, Lang Z, Shepherd L, et al., 2016, Novel pH sensing semiconductor for point-of-care detection of HIV-1 viremia, Scientific Reports, Vol:6, ISSN:2045-2322

Stanaway JD, Flaxman AD, Naghavi M, et al., 2016, The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013, The Lancet, Vol:388, ISSN:0140-6736, Pages:1081-1088

Simmons B, Saleem J, Hill A, et al., 2016, Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis, Clinical Infectious Diseases, Vol:62, ISSN:1058-4838, Pages:683-694

Simmons B, Saleem J, Heath K, et al., 2015, Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response, Clinical Infectious Diseases, Vol:61, ISSN:1058-4838, Pages:730-740

Rao VB, Johari N, du Cros P, et al., 2015, Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis, Lancet Infectious Diseases, Vol:15, ISSN:1473-3099, Pages:819-824

van de Ven N, Fortunak J, Simmons B, et al., 2015, Minimum Target Prices for Production of Direct-Acting Antivirals and Associated Diagnostics to Combat Hepatitis C Virus, Hepatology, Vol:61, ISSN:1527-3350, Pages:1174-1182

Messina JP, Humphreys I, Flaxman A, et al., 2015, Global Distribution and Prevalence of Hepatitis C Virus Genotypes, Hepatology, Vol:61, ISSN:0270-9139, Pages:77-87

Hill A, Cooke G, 2014, Hepatitis C can be cured globally, but at what cost?, Science, Vol:345, ISSN:0036-8075, Pages:141-142

More Publications